127 related articles for article (PubMed ID: 36006680)
1. Apoptosis-Sensing Xenograft Zebrafish Tumor Model for Anticancer Evaluation of Redox-Responsive Cross-Linked Pluronic Micelles.
Tao J; Wei Z; Cheng Y; Xu M; Li Q; Lee SM; Ge W; Luo KQ; Wang X; Zheng Y
ACS Appl Mater Interfaces; 2022 Sep; 14(35):39775-39786. PubMed ID: 36006680
[TBL] [Abstract][Full Text] [Related]
2. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
3. Pluronic F127-based micelles for tumor-targeted bufalin delivery.
Wang H; Williams GR; Wu J; Wu J; Niu S; Xie X; Li S; Zhu LM
Int J Pharm; 2019 Mar; 559():289-298. PubMed ID: 30707933
[TBL] [Abstract][Full Text] [Related]
4. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
[TBL] [Abstract][Full Text] [Related]
5. pH/redox dual-responsive amphiphilic zwitterionic polymers with a precisely controlled structure as anti-cancer drug carriers.
Wu Z; Gan Z; Chen B; Chen F; Cao J; Luo X
Biomater Sci; 2019 Aug; 7(8):3190-3203. PubMed ID: 31145392
[TBL] [Abstract][Full Text] [Related]
6. A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy.
Liu N; Tan Y; Hu Y; Meng T; Wen L; Liu J; Cheng B; Yuan H; Huang X; Hu F
ACS Appl Mater Interfaces; 2016 Dec; 8(48):33148-33156. PubMed ID: 27934140
[TBL] [Abstract][Full Text] [Related]
7. Disulfide cross-linked polyurethane micelles as a reduction-triggered drug delivery system for cancer therapy.
Yu S; Ding J; He C; Cao Y; Xu W; Chen X
Adv Healthc Mater; 2014 May; 3(5):752-60. PubMed ID: 24574261
[TBL] [Abstract][Full Text] [Related]
8. TME-Responsive Polyprodrug Micelles for Multistage Delivery of Doxorubicin with Improved Cancer Therapeutic Efficacy in Rodents.
Zhang S; Zhu P; He J; Dong S; Li P; Zhang CY; Ma T
Adv Healthc Mater; 2020 Sep; 9(18):e2000387. PubMed ID: 32815646
[TBL] [Abstract][Full Text] [Related]
9. Redox-Responsive Polyphosphoester-Based Micellar Nanomedicines for Overriding Chemoresistance in Breast Cancer Cells.
Ma YC; Wang JX; Tao W; Sun CY; Wang YC; Li DD; Fan F; Qian HS; Yang XZ
ACS Appl Mater Interfaces; 2015 Dec; 7(47):26315-25. PubMed ID: 26552849
[TBL] [Abstract][Full Text] [Related]
10. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
[TBL] [Abstract][Full Text] [Related]
11. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
[TBL] [Abstract][Full Text] [Related]
12. Redox-Responsive Core-Cross-Linked Block Copolymer Micelles for Overcoming Multidrug Resistance in Cancer Cells.
Maiti C; Parida S; Kayal S; Maiti S; Mandal M; Dhara D
ACS Appl Mater Interfaces; 2018 Feb; 10(6):5318-5330. PubMed ID: 29355017
[TBL] [Abstract][Full Text] [Related]
13. Redox-Responsive Amphipathic Dextran Nanomicelles for Solid Tumor Therapy.
Song Y; Lou B; Cheng J; Zhao P; Lin C; Wen X
J Biomed Nanotechnol; 2016 Dec; 12(12):2083-96. PubMed ID: 29368837
[TBL] [Abstract][Full Text] [Related]
14. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
[TBL] [Abstract][Full Text] [Related]
15. Reduction/temperature/pH multi-stimuli responsive core cross-linked polypeptide hybrid micelles for triggered and intracellular drug release.
Qu J; Wang QY; Chen KL; Luo JB; Zhou QH; Lin J
Colloids Surf B Biointerfaces; 2018 Oct; 170():373-381. PubMed ID: 29940504
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment-responsive micelles for pinpointed intracellular release of doxorubicin and enhanced anti-cancer efficiency.
Chen WL; Yang SD; Li F; Li JZ; Yuan ZQ; Zhu WJ; Liu Y; Zhou XF; Liu C; Zhang XN
Int J Pharm; 2016 Sep; 511(2):728-40. PubMed ID: 27484835
[TBL] [Abstract][Full Text] [Related]
17. Smart pH-sensitive micelles based on redox degradable polymers as DOX/GNPs carriers for controlled drug release and CT imaging.
Xiong D; Zhang X; Peng S; Gu H; Zhang L
Colloids Surf B Biointerfaces; 2018 Mar; 163():29-40. PubMed ID: 29278801
[TBL] [Abstract][Full Text] [Related]
18. Intracellular Doxorubicin Delivery of a Core Cross-linked, Redox-responsive Polymeric Micelles.
Lili Y; Ruihua M; Li L; Fei L; Lin Y; Li S
Int J Pharm; 2016 Feb; 498(1-2):195-204. PubMed ID: 26706436
[TBL] [Abstract][Full Text] [Related]
19. Redox and pH Dual-Responsive Polymeric Micelles with Aggregation-Induced Emission Feature for Cellular Imaging and Chemotherapy.
Zhuang W; Xu Y; Li G; Hu J; Ma B; Yu T; Su X; Wang Y
ACS Appl Mater Interfaces; 2018 Jun; 10(22):18489-18498. PubMed ID: 29737837
[TBL] [Abstract][Full Text] [Related]
20. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy.
Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M
ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
